(13 days)
Not Found
No
The document does not mention AI, ML, or any related terms, and the description focuses on standard ultrasound technology and cardiac packages.
No
The device is described as an "APLIO Ultrasound System" intended for various diagnostic imaging studies and "to clear cardiac packages already in place on predicate devices." There is no mention of it being used for treatment or therapy.
Yes
The device is an ultrasound system intended for various medical studies, and its predicate devices are explicitly named as "Diagnostic Ultrasound" systems. This indicates its use in diagnosing medical conditions.
No
The device description explicitly states it is a "mobile system" and employs "a wide array of probes," which are hardware components. The submission is for clearing "cardiac packages," which are likely software features, but the underlying device is a physical ultrasound system.
Based on the provided information, the APLIO Ultrasound System is not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD devices are used to examine specimens (like blood, urine, or tissue) taken from the human body. They are used in vitro (outside the body) to provide information about a person's health.
- The APLIO Ultrasound System is used for imaging the inside of the body in vivo (within the body). It uses ultrasound waves to create images of organs and tissues.
The description clearly states the intended use is for various types of studies performed directly on patients (fetal, abdominal, cardiac, etc.) and the device description confirms it's a mobile system used for imaging. There is no mention of analyzing biological specimens.
N/A
Intended Use / Indications for Use
The APLIO is intended to be used for the following type of studies; fetal, abdominal, intraoperative, pediatric, small organs, neonatal cephalic, adult cephalic, cardiac, transrectal, transvaginal, transesophageal, peripheral vascular, musculo-skeletal (both conventional and superficial) and laparoscopic.
Product codes (comma separated list FDA assigned to the subject device)
90-IYN, 90-IYO, 90-ITX
Device Description
The APLIO Ultrasound System is a mobile system. This system is a Track 3 device that employs a wide array of probes that include flat linear array, convex linear array, and sector array with a frequency range of approximately 2 MHz to 12 MHz. This submission is to clear cardiac packages already in place on predicate devices.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasonic pulsed doppler imaging, Ultrasonic pulsed echo imaging
Anatomical Site
Fetal, Abdominal, Intraoperative, Pediatric, Small Organ (thyroid, parathyroid, breast, scrotum and penis), Neonatal Cephalic, Adult Cephalic, Cardiac, Transrectal, Transvaginal, Transesophageal, Peripheral Vascular, Musculo-skeletal (both conventional and superficial), Laparoscopic
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K013633, K022400, K022567, K991842
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1550 Ultrasonic pulsed doppler imaging system.
(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
510(k) Summary of Safety and Effectiveness: 21 CFR 807.92
Submitter's Name: Toshiba America Medical Systems, Inc. | |
---|---|
Address: | PO Box 2068,2441 Michelle Drive Tustin, CA 92781-2068 |
Contact: | Paul Biggins, Sr. Manager of Regulatory Affairs |
Telephone No .: | (714) 730-5000 |
Facsimile No .: | (714) 730-1310 |
Device Proprietary Name: | SSA-770A, APLIO Version 4 |
---|---|
Common Name: | Diagnostic Ultrasound System |
Classification:
Regulatory Class: | II |
---|---|
Review Category: | Tier II |
Panel: | Radiology |
Ultrasonic Pulsed Doppler Imaging System - Product Code: 90-IYN [Fed.Reg.No.:892.1550] Ultrasonic Pulsed Echo Imaging System - Product Code: 90-IYO [Fed.Reg.No .: 892.1560] Diagnostic Ultrasonic Transducer - Product Code: 90-ITX [Fed. Reg. No .: 892.1570]
Identification of Predicate Devices:
Toshiba America Medical Systems believes that this device is substantially equivalent to:
-
- Toshiba SSA-770A, Aplio Diagnostic Ultrasound; 510(k) control number K013633
-
- Toshiba SSA-700A, AplioSL Diagnostic Ultrasound; 510(k) control number K022400
-
- Acuson Sequoia Signature II Diagnostic Ultrasound; 510(k) control number K022567
-
- GE Vingmed Ultrasound System FiVe, 510(k) control number K991842.
Device Description:
The APLIO Ultrasound System is a mobile system. This system is a Track 3 device that employs a wide array of probes that include flat linear array, convex linear array, and sector array with a frequency range of approximately 2 MHz to 12 MHz. This submission is to clear cardiac packages already in place on predicate devices.
Intended Use:
The APLIO is intended to be used for the following type of studies; fetal, abdominal, intraoperative, pediatric, small organs, neonatal cephalic, adult cephalic, cardiac, transrectal, transvaginal, transesophageal, peripheral vascular, musculo-skeletal (both conventional and superficial) and laparoscopic.
Safety Considerations:
This device is designed and manufactured in conjunction with the Quality System Regulation, IEC 60601 (applicable portions), IEC60601-2-37 (applicable portions), and the AIUM-NEMA UD2 Output Measurement Standard as applied to Track 3 Ultrasound systems and the AIUM-NEMA UD3 Output Display Standard.
1
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" around the perimeter. Inside the circle is an abstract symbol resembling an eagle or bird in flight, composed of three curved lines.
Public Health Service
AUG - 6 2003
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Toshiba America Medical Systems, Inc. % Ms. Laura Danielson Responsible Third Party TÜV Product Service 1775 Old Highway 8 NEW BRIGHTON MN 55112-1891
Re: K032281
Trade Name: SSA-770A - Version 4, APLIO Diagnostic Ultrasound System Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulation Number: 21 CFR 892.1560 Regulation Name: Ultrasonic pulsed echo imaging system Regulation Number: 21 CFR 892.1570 Regulation Name: Diagnostic ultrasonic transducer Regulatory Class: II Product Code: 90 IYN, IYO, and ITX Dated: July 23, 2003 Received: July 24, 2003
Dear Ms. Danielson:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
This determination of substantial equivalence applies to the following transducers intended for use with the SSA-770A - Version 4, APLIO Diagnostic Ultrasound System, as described in your premarket notification:
Transducer Model Number
PST-25AT PVT-375AT
2
PVT-661VT PLT-805AT PST-20CT PLT-1204AX PC-20M PET-510MB PLT-1202S PET-704LA PST-37CT PST-30BT PLT-704AT PLT-1204AT PVT-375AX PST-65AT PLT-604AT PST-50AT PLT-308P
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This determination of substantial equivalence is granted on the condition that prior to shipping the first device, you submit a postclearance special report. This report should contain complete information, including acoustic output measurements based on production line devices, requested in Appendix G, (enclosed) of the Center's September 30, 1997 "Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers." If the special report is incomplete or contains unacceptable values (e.g., acoustic output greater than approved levels), then the 510(k) clearance may not apply to the production units which as a result may be considered adulterated or misbranded.
The special report should reference the manufacturer's 510(k) number. It should be clearly and prominently marked "ADD-TO-FILE" and should be submitted in duplicate to:
3
Food and Drug Administration Center for Devices and Radiological Health Document Mail Center (HFZ-401) 9200 Corporate Boulevard Rockville, Maryland 20850
This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801, please contact the Office of Compliance at (301) 594-4591. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or at (301) 443-6597 or at its Internet address "http://www.fda.gov/cdrh/dsmamain.html".
If you have any questions regarding the content of this letter, please contact Rodrigo C. Perez at (301) 594-1212.
Sincerely yours,
David A. Lygram
Nancy C. Brogdon
Director, Division of Reproductive,
Abdominal and Radiological Devices
Office of Device Evaluation
Center for Devices and Radiological Health
Enclosure(s)
4
Transducer System X
Model SSA-770A 510(k) Number(s)
510(k) Number(s)
Mode of Operation | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | B | M | P | |||||||||
W | ||||||||||||
D | C | |||||||||||
W | ||||||||||||
D | Color | |||||||||||
Doppler | Amplitude | |||||||||||
Doppler | Color | |||||||||||
Velocity | ||||||||||||
Imaging | Combined | |||||||||||
(Specify) | Harmonic | |||||||||||
Imaging | 1.5 | |||||||||||
THI | 1.5 | |||||||||||
RSI | TDI- | |||||||||||
Q | ||||||||||||
Ophthalmic | ||||||||||||
Fetal | P | P | P | P | P | P | P | P | P | |||
Abdominal | P | P | P | P | P | P | P | P | P | |||
Intraoperative (Specify)** | P | P | P | P | P | P | P | P | P | |||
Intraoperative | ||||||||||||
Neurological | ||||||||||||
Pediatric | P | P | P | P | P | P | P | P | P | |||
Small Organ (Specify)*** | P | P | P | P | P | P | P | P | P | |||
Neonatal Cephalic | P | P | P | P | P | P | P | P | P | |||
Adult Cephalic | P | P | P | P | P | P | P | P | P | |||
Cardiac | P | P | P | P | P | P | P | P | P | E1 | N | N |
Transesophageal | P | P | P | P | P | P | P | P | P | E1 | N | |
Transrectal | P | P | P | P | P | P | P | P | P | |||
Transvaginal | P | P | P | P | P | P | P | P | P | |||
Transurethral | ||||||||||||
Intravascular | ||||||||||||
Peripheral Vascular | P | P | P | P | P | P | P | P | P | |||
Laparoscopic | P | P | P | P | P | P | P | P | ||||
Musculo-skeletal | P | P | P | P | P | P | P | P | P | |||
Superficial | ||||||||||||
Musculo-skeletal | ||||||||||||
Conventional | P | P | P | P | P | P | P | P | P |
N= new indication; P = Previously Cleared by FDA; E = Added under Appendix E (LTF)
Additional Comments: Combined Modes: B/M; B/PWD; BDF/PWD; BDF/MDF; BDF/MDF/PWD;B-TDI; M-TDI; 2D/CWD; BDF/CWD; CHI/2D; FEI/2D; CHI/BDF; FEI/BDF; FEI/BDF
E 1 – Added via LTF against SSA-700A 510(k) control number K022400 |
---|
Previous 510(k) for this device K013633 |
** Abdominal |
*** For example: thyroid, parathyroid, breast, scrotum and penis |
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON OTHER PAGES IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
DAS
Division Sign-Off
and Radiological De 510(k) Number
5
Transducer X System Model PST-25AT 510(k) Number(s)
Mode of Operation | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | B | M | P | |||||||||
W | ||||||||||||
D | C | |||||||||||
W | ||||||||||||
D | Color | |||||||||||
Doppler | Amplitude | |||||||||||
Doppler | Color | |||||||||||
Velocity | ||||||||||||
Imaging | Combined | |||||||||||
(Specify) | Harmonic | |||||||||||
Imaging | 1.5 | |||||||||||
THI | 1.5 | |||||||||||
RSI | TDI- | |||||||||||
Q | ||||||||||||
Ophthalmic | ||||||||||||
Fetal | ||||||||||||
Abdominal | ||||||||||||
Intraoperative (Specify) | ||||||||||||
Intraoperative | ||||||||||||
Neurological | ||||||||||||
Pediatric | P | P | P | P | P | P | P | P | P | |||
Small Organ (Specify) | ||||||||||||
Neonatal Cephalic | ||||||||||||
Adult Cephalic | ||||||||||||
Cardiac | P | P | P | P | P | P | P | P | P | E 1 | N | |
Transesophageal | ||||||||||||
Transrectal | ||||||||||||
Transvaginal | ||||||||||||
Transurethral | ||||||||||||
Intravascular | ||||||||||||
Peripheral Vascular | ||||||||||||
Laparoscopic | ||||||||||||
Musculo-skeletal | ||||||||||||
Superficial | ||||||||||||
Musculo-skeletal | ||||||||||||
Conventional |
N= new indication; P = Previously Cleared by FDA; E = Added under Appendix E (LTF)
Additional Comments: Combined Modes: B/M; B/PWD; BDF/PWD; BDF/MDF; BDF/MDF/PWD;B-TDI; M-TDI; 2D/CWD; BDF/CWD; CHI/2D; FEI/2D; CHI/BDF; FEI/BDF
E'- Added via LTF against SSA-700A 510(k) control number K022400 Previous 510(k) for this device K013633
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON OTHER PAGES IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
Daniel A. Seymour
(Division Sign-O Divisio and Radiological D 510(k) Numbe
6
Transducer X System PVT-375AT Model 510(k) Number(s)
Mode of Operation | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | B | M | P | |||||||||
W | ||||||||||||
D | C | |||||||||||
W | ||||||||||||
D | Color | |||||||||||
Doppler | Amplitude | |||||||||||
Doppler | Color | |||||||||||
Velocity | ||||||||||||
Imaging | Combined | |||||||||||
(Specify) | Harmonic | |||||||||||
Imaging | 1.5 | |||||||||||
THI | 1.5 | |||||||||||
RSI | TDI-Q | |||||||||||
Ophthalmic | ||||||||||||
Fetal | P | P | P | P | P | P | P | P | ||||
Abdominal | P | P | P | P | P | P | P | P | ||||
Intraoperative (Specify) | ||||||||||||
Intraoperative Neurological | ||||||||||||
Pediatric | P | P | P | P | P | P | P | P | ||||
Small Organ (Specify) | ||||||||||||
Neonatal Cephalic | ||||||||||||
Adult Cephalic | ||||||||||||
Cardiac | ||||||||||||
Transesophageal | ||||||||||||
Transrectal | ||||||||||||
Transvaginal | ||||||||||||
Transurethral | ||||||||||||
Intravascular | ||||||||||||
Peripheral Vascular | ||||||||||||
Laparoscopic | ||||||||||||
Musculo-skeletal Superficial | ||||||||||||
Musculo-skeletal | ||||||||||||
Conventional |
N= new indication; P = Previously Cleared by FDA; E = Added under Appendix E (LTF)
Combined Modes: B/M; B/PWD; Additional Comments: BDF/PWD; BDF/MDF; BDF/MDF/PWD;B-TDI; M-TDI; 2D/CWD; BDF/CWD; CHI/2D; FEI/2D; CHI/BDF; FEI/BDF
Previous 510(k) for this device K013633
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON OTHER PAGES IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
David A. Segerson
(Division Sign-Off) Division of Reproduct and Radiological Devic 510(k) Number
7
Transducer X System PVT-661VT Model 510(k) Number(s)
Mode of Operation | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | B | M | P | |||||||||
W | ||||||||||||
D | C | |||||||||||
W | ||||||||||||
D | Color | |||||||||||
Doppler | Amplitude | |||||||||||
Doppler | Color | |||||||||||
Velocity | ||||||||||||
Imaging | Combined | |||||||||||
(Specify) | Harmonic | |||||||||||
Imaging | 1.5 | |||||||||||
THI | 1.5 | |||||||||||
RSI | TDI- | |||||||||||
Q | ||||||||||||
Ophthalmic | ||||||||||||
Fetal | ||||||||||||
Abdominal | ||||||||||||
Intraoperative (Specify) | ||||||||||||
Intraoperative | ||||||||||||
Neurological | ||||||||||||
Pediatric | ||||||||||||
Small Organ (Specify) | ||||||||||||
Neonatal Cephalic | ||||||||||||
Adult Cephalic | ||||||||||||
Cardiac | ||||||||||||
Transesophageal | ||||||||||||
Transrectal | P | P | P | P | P | P | P | P | ||||
Transvaginal | B | P | P | P | P | P | P | P | ||||
Transurethral | ||||||||||||
Intravascular | ||||||||||||
Peripheral Vascular | ||||||||||||
Laparoscopic | ||||||||||||
Musculo-skeletal | ||||||||||||
Superficial | ||||||||||||
Musculo-skeletal | ||||||||||||
Conventional |
N= new indication; P = Previously Cleared by FDA; E = Added under Appendix E (LTF)
Additional Comments: Combined Modes: B/M; B/PWD: BDF/PWD; BDF/MDF; BDF/MDF/PWD;B-TDI; M-TDI; 2D/CWD; BDF/CWD; CHI/2D; FEI/2D; CHI/BDF; FEVBDF
Previous 510(k) for this device K013633
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON OTHER PAGES IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
David A. Ingram
8
Transducer _X System PLT-805AT Model 510(k) Number(s)
Mode of Operation | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
B | M | P | ||||||||||
W | ||||||||||||
D | C | |||||||||||
W | ||||||||||||
D | Color | |||||||||||
Doppler | Amplitude | |||||||||||
Doppler | Color | |||||||||||
Velocity | ||||||||||||
Imaging | Combined | |||||||||||
(Specify) | Harmonic | |||||||||||
Imaging | 1.5 | |||||||||||
THI | 1.5 | |||||||||||
RSI | TDI-Q | |||||||||||
Clinical Application | ||||||||||||
Ophthalmic | ||||||||||||
Fetal | ||||||||||||
Abdominal | ||||||||||||
Intraoperative (Specify) | ||||||||||||
Intraoperative | ||||||||||||
Neurological | ||||||||||||
Pediatric | ||||||||||||
Small Organ (Specify)*** | P | P | P | P | P | P | P | P | ||||
Neonatal Cephalic | ||||||||||||
Adult Cephalic | ||||||||||||
Cardiac | ||||||||||||
Transesophageal | ||||||||||||
Transrectal | ||||||||||||
Transvaginal | ||||||||||||
Transurethral | ||||||||||||
Intravascular | ||||||||||||
Peripheral Vascular | P | P | P | P | P | P | P | P | ||||
Laparoscopic | ||||||||||||
Musculo-skeletal | ||||||||||||
Superficial | P | P | P | P | P | P | P | P | ||||
Musculo-skeletal | ||||||||||||
Conventional | P | P | P | P | P | P | P | P |
N= new indication; P = Previously Cleared by FDA; E = Added under Appendix E (LTF)
Additional Comments: Combined Modes: B/M; B/PWD; BDF/PWD; BDF/MDF; BDF/MDF/PWD;B-TDI; M-TDI; 2D/CWD; BDF/CWD; CHI/2D; FEI/2D; CHI/BDF; FEI/BDF
*** For example: thyroid, parathyroid, breast, scrotum and penis Previous 510(k) for this device K013633
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON OTHER PAGES IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
David A. Serson
9
Transducer _X System
PST-20CT Model 510(k) Number(s)
Mode of Operation | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | B | M | P | |||||||||
W | ||||||||||||
D | C | |||||||||||
W | ||||||||||||
D | Color | |||||||||||
Doppler | Amplitude | |||||||||||
Doppler | Color | |||||||||||
Velocity | ||||||||||||
Imaging | Combined | |||||||||||
(Specify) | Harmonic | |||||||||||
Imaging | 1.5 | |||||||||||
THI | 1.5 | |||||||||||
RSI | TDI-Q | |||||||||||
Ophthalmic | ||||||||||||
Fetal | P | P | P | P | P | P | P | P | P | |||
Abdominal | ||||||||||||
Intraoperative (Specify) | ||||||||||||
Intraoperative | ||||||||||||
Neurological | ||||||||||||
Pediatric | ||||||||||||
Small Organ (Specify) | ||||||||||||
Neonatal Cephalic | P | P | P | P | P | P | P | P | P | |||
Adult Cephalic | P | P | P | P | P | P | P | P | P | |||
Cardiac | P | P | P | P | P | P | P | P | P | |||
Transesophageal | ||||||||||||
Transrectal | ||||||||||||
Transvaginal | ||||||||||||
Transurethral | ||||||||||||
Intravascular | ||||||||||||
Peripheral Vascular | ||||||||||||
Laparoscopic | ||||||||||||
Musculo-skeletal | ||||||||||||
Superficial | ||||||||||||
Musculo-skeletal | ||||||||||||
Conventional |
N= new indication; P = Previously Cleared by FDA; E = Added under Appendix E (LTF)
Combined Modes: B/M; B/PWD; Additional Comments: BDF/PWD; BDF/MDF; BDF/MDF/PWD;B-TDI; M-TDI; 2D/CWD; BDF/CWD; CHI/2D; FEI/2D; CHI/BDF; FEI/BDF; FEI/BDF
Previous 510(k) for this device K013633
(PLEASE DO NOT WRITE BELOW THIS ( DNE - CONTINUE ON OTHER I Concurrence of CDRH, Office of Device Evaluation (C
David A. Seymann
Divisi and R 510(k) Numb
10
Transducer _X System PLT-1204AX Model 510(k) Number(s)
Mode of Operation | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | B | M | P | C | Color Doppler | Amplitude Doppler | Color Velocity Imaging | Combined (Specify) | Harmonic Imaging | 1.5 THI | 1.5 RSI | TDI-Q |
Ophthalmic | ||||||||||||
Fetal | ||||||||||||
Abdominal | ||||||||||||
Intraoperative (Specify) | ||||||||||||
Intraoperative | ||||||||||||
Neurological | ||||||||||||
Pediatric | ||||||||||||
Small Organ (Specify)*** | P | P | P | P | P | P | P | P | ||||
Neonatal Cephalic | ||||||||||||
Adult Cephalic | ||||||||||||
Cardiac | ||||||||||||
Transesophageal | ||||||||||||
Transrectal | ||||||||||||
Transvaginal | ||||||||||||
Transurethral | ||||||||||||
Intravascular | ||||||||||||
Peripheral Vascular | P | P | P | P | P | P | P | P | ||||
Laparoscopic | ||||||||||||
Musculo-skeletal Superficial | P | P | P | P | P | P | P | P | ||||
Musculo-skeletal Conventional | P | P | P | P | P | P | P | P |
N= new indication; P = Previously Cleared by FDA; E = Added under Appendix E (LTF)
Combined Modes: B/M; B/PWD; Additional Comments: BDF/PWD; BDF/MDF; BDF/MDF/PWD;B-TDI; M-TDI; 2D/CWD; BDF/CWD; CHI/2D; FEI/2D; CHI/BDF; FEI/BDF
Previous 510(k) for this device K013633
*** For example: thyroid, parathyroid, breast, scrotum and penis
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON OTHER PAGES IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
David A. Hyman
(Division Sian-Off Division of Renmolue and Radiological De 510(k) Numbe
11
Transducer X System Model PC-20M 510(k) Number(s)
Mode of Operation | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | B | M | P | |||||||||
W | ||||||||||||
D | C | |||||||||||
W | ||||||||||||
D | Color | |||||||||||
Doppler | Amplitude | |||||||||||
Doppler | Color | |||||||||||
Velocity | ||||||||||||
Imaging | Combined | |||||||||||
(Specify) | Harmonic | |||||||||||
Imaging | 1.5 | |||||||||||
THI | 1.5 | |||||||||||
RSI | TDI-Q | |||||||||||
Ophthalmic | ||||||||||||
Fetal | ||||||||||||
Abdominal | ||||||||||||
Intraoperative (Specify) | ||||||||||||
Intraoperative | ||||||||||||
Neurological | ||||||||||||
Pediatric | P | |||||||||||
Small Organ (Specify) | ||||||||||||
Neonatal Cephalic | ||||||||||||
Adult Cephalic | ||||||||||||
Cardiac | P | |||||||||||
Transesophageal | ||||||||||||
Transrectal | ||||||||||||
Transvaginal | ||||||||||||
Transurethral | ||||||||||||
Intravascular | ||||||||||||
Peripheral Vascular | ||||||||||||
Laparoscopic | ||||||||||||
Musculo-skeletal | ||||||||||||
Superficial | ||||||||||||
Musculo-skeletal | ||||||||||||
Conventional |
N= new indication; P = Previously Cleared by FDA; E = Added under Appendix E (LTF)
Additional Comments: ________________________________________________________________________________________________________________________________________________________ Combined Modes: B/M; B/PWD; BDF/PWD; BDF/MDF; BDF/MDF/PWD;B-TDI; M-TDI; 2D/CWD; BDF/CWD; CHI/2D; FEI/2D; CHI/BDF; FEI/BDF; FEI/BDF
Previous 510(k) for this device K013633
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON OTHER PAGES IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
Daniel A. Hagman
(Division Sign-Off Division of Reproductive and Radiological Devic 510(k) Number
12
Transducer X System Model PET-510MB 510(k) Number(s)
| Clinical Application | B | M | P
W
D | C
W
D | Color
Doppler | Amplitude
Doppler | Color
Velocity
Imaging | Combined
(Specify) | Harmonic
Imaging | 1.5
THI | 1.5
RSI | TDI-Q |
|----------------------------------|---|---|-------------|-------------|------------------|----------------------|------------------------------|-----------------------|---------------------|------------|------------|-------|
| Ophthalmic | | | | | | | | | | | | |
| Fetal | | | | | | | | | | | | |
| Abdominal | | | | | | | | | | | | |
| Intraoperative (Specify) | | | | | | | | | | | | |
| Intraoperative | | | | | | | | | | | | |
| Neurological | | | | | | | | | | | | |
| Pediatric | | | | | | | | | | | | |
| Small Organ (Specify) | | | | | | | | | | | | |
| Neonatal Cephalic | | | | | | | | | | | | |
| Adult Cephalic | | | | | | | | | | | | |
| Cardiac | | | | | | | | | | | | |
| Transesophageal | P | P | P | P | P | P | P | P | P | E¹ | | N |
| Transrectal | | | | | | | | | | | | |
| Transvaginal | | | | | | | | | | | | |
| Transurethral | | | | | | | | | | | | |
| Intravascular | | | | | | | | | | | | |
| Peripheral Vascular | | | | | | | | | | | | |
| Laparoscopic | | | | | | | | | | | | |
| Musculo-skeletal | | | | | | | | | | | | |
| Superficial | | | | | | | | | | | | |
| Musculo-skeletal
Conventional | | | | | | | | | | | | |
N= new indication; P = Previously Cleared by FDA; E = Added under Appendix E (LTF)
Additional Comments: Combined Modes: B/M; B/PWD; BDF/PWD; BDF/MDF; BDF/MDF/PWD;B-TDI; M-TDI; 2D/CWD; BDF/CWD; CHI/2D; FEI/2D; CHI/BDF; FEI/BDF
E'- Added via LTF against SSA-700A 510(k) control number K022400 Previous 510(k) for this device K013633
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON OTHER PAGES IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
David A. Lyman
of Reproductive 510k) Numb
13
Transducer X System PLT-1202S Model 510(k) Number(s)
Mode of Operation | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | B | M | P | |||||||||
W | ||||||||||||
D | C | |||||||||||
W | ||||||||||||
D | Color | |||||||||||
Doppler | Amplitude | |||||||||||
Doppler | Color | |||||||||||
Velocity | ||||||||||||
Imaging | Combined | |||||||||||
(Specify) | Harmonic | |||||||||||
Imaging | 1.5 | |||||||||||
THI | 1.5 | |||||||||||
RSI | TDI- | |||||||||||
Q | ||||||||||||
Ophthalmic | ||||||||||||
Fetal | ||||||||||||
Abdominal | ||||||||||||
Intraoperative (Specify) | P | P | P | P | P | P | P | P | ||||
Intraoperative Neurological | ||||||||||||
Pediatric | ||||||||||||
Small Organ (Specify)*** | P | P | P | P | P | P | P | P | ||||
Neonatal Cephalic | ||||||||||||
Adult Cephalic | ||||||||||||
Cardiac | ||||||||||||
Transesophageal | ||||||||||||
Transrectal | ||||||||||||
Transvaginal | ||||||||||||
Transurethral | ||||||||||||
Intravascular | ||||||||||||
Peripheral Vascular | P | P | P | P | P | P | P | P | ||||
Laparoscopic | ||||||||||||
Musculo-skeletal Superficial | P | P | P | P | P | P | P | P | ||||
Musculo-skeletal | ||||||||||||
Conventional | P | P | P | P | P | P | P | P |
N= new indication; P = Previously Cleared by FDA; E = Added under Appendix E (LTF)
Additional Comments: Combined Modes: B/M; B/PWD; BDF/PWD; BDF/MDF; BDF/MDF/PWD;B-TDI; M-TDI; 2D/CWD; BDF/CWD; CHI/2D; FEI/2D; CHI/BDF; FEI/BDF
Previous 510(k) for this device K013633 *** For example: thyroid, parathyroid, breast, scrotum and penis
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON OTHER PAGES IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
David R. Segerson
(Division Sign-Off) Division of Reproductive, Abdominal, and Radiological Devices 510(k) Number _
14
Transducer X System PET-704LA Model 510(k) Number(s)
Mode of Operation | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | B | M | PWD | CWD | Color Doppler | Amplitude Doppler | Color Velocity Imaging | Combined (Specify) | Harmonic Imaging | 1.5 THI | 1.5 RSI | TDI-Q |
Ophthalmic | ||||||||||||
Fetal | ||||||||||||
Abdominal | ||||||||||||
Intraoperative (Specify) | ||||||||||||
Intraoperative | ||||||||||||
Neurological | ||||||||||||
Pediatric | ||||||||||||
Small Organ (Specify) | ||||||||||||
Neonatal Cephalic | ||||||||||||
Adult Cephalic | ||||||||||||
Cardiac | ||||||||||||
Transesophageal | ||||||||||||
Transrectal | ||||||||||||
Transvaginal | ||||||||||||
Transurethral | ||||||||||||
Intravascular | ||||||||||||
Peripheral Vascular | ||||||||||||
Laparoscopic | P | P | P | P | P | P | P | |||||
Musculo-skeletal | ||||||||||||
Superficial | ||||||||||||
Musculo-skeletal | ||||||||||||
Conventional |
N= new indication; P = Previously Cleared by FDA; E = Added under Appendix E (LTF)
Combined Modes: B/M; B/PWD; Additional Comments: ________________________________________________________________________________________________________________________________________________________ BDF/PWD; BDF/MDF; BDF/MDF/PWD;B-TDI; M-TDI; 2D/CWD; BDF/CWD; CHI/2D; FEI/2D; CHI/BDF; FEI/BDF
Previous 510(k) for this device K013633
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON OTHER PAGES IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
Daniel A. Szyman
(Division Sign-Off Division of Reproductive. Abd and Radiological Devic 510(k) Number
15
System Transducer X PST-37CT Model 510(k) Number(s)
Mode of Operation | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | B | M | P | |||||||||
W | ||||||||||||
D | C | |||||||||||
W | ||||||||||||
D | Color | |||||||||||
Doppler | Amplitude | |||||||||||
Doppler | Color | |||||||||||
Velocity | ||||||||||||
Imaging | Combined | |||||||||||
(Specify) | Harmonic | |||||||||||
Imaging | 1.5 | |||||||||||
THI | 1.5 | |||||||||||
RSI | TDI-Q | |||||||||||
Ophthalmic | ||||||||||||
Fetal | E | E | E | E | E | E | E | E | E | |||
Abdominal | E | E | E | E | E | E | E | E | ||||
Intraoperative (Specify) | ||||||||||||
Intraoperative | ||||||||||||
Neurological | ||||||||||||
Pediatric | E | E | E | E | E | E | E | E | E | |||
Small Organ (Specify) | ||||||||||||
Neonatal Cephalic | ||||||||||||
Adult Cephalic | ||||||||||||
Cardiac | ||||||||||||
Transesophageal | ||||||||||||
Transrectal | ||||||||||||
Transvaginal | ||||||||||||
Transurethral | ||||||||||||
Intravascular | ||||||||||||
Peripheral Vascular | ||||||||||||
Laparoscopic | ||||||||||||
Musculo-skeletal | ||||||||||||
Superficial | ||||||||||||
Musculo-skeletal | ||||||||||||
Conventional |
N= new indication; P = Previously Cleared by FDA; E = Added under Appendix E (LTF)
Additional Comments: Combined Modes: B/M; B/PWD; BDF/PWD; BDF/MDF; BDF/MDF/PWD;B-TDI; M-TDI; 2D/CWD; BDF/CWD; CHI/2D; FEI/2D; CHI/BDF; FEI/BDF
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON OTHER PAGE Concurrence of CDRH, Office of Device Evaluation (
David A. Seymour
(Division Sign-Off) Division of Reproductive. and Rac 510(k) Numb
16
Transducer _X System PST-30BT Model 510(k) Number(s)
.
Mode of Operation | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | B | M | P | |||||||||
W | ||||||||||||
D | C | |||||||||||
W | ||||||||||||
D | Color | |||||||||||
Doppler | Amplitude | |||||||||||
Doppler | Color | |||||||||||
Velocity | ||||||||||||
Imaging | Combined | |||||||||||
(Specify) | Harmonic | |||||||||||
Imaging | 1.5 | |||||||||||
THI | 1.5 | |||||||||||
RSI | TDI-Q | |||||||||||
Ophthalmic | ||||||||||||
Fetal | ||||||||||||
Abdominal | ||||||||||||
Intraoperative | ||||||||||||
(Specify) | ||||||||||||
Intraoperative | ||||||||||||
Neurological | ||||||||||||
Pediatric | E | E | E | E | E | E | E | E | E | |||
Small Organ | ||||||||||||
(Specify) | ||||||||||||
Neonatal Cephalic | ||||||||||||
Adult Cephalic | ||||||||||||
Cardiac | E | E | E | E | E | E | E | E | E | E | N | N |
Transesophageal | ||||||||||||
Transrectal | ||||||||||||
Transvaginal | ||||||||||||
Transurethral | ||||||||||||
Intravascular | ||||||||||||
Peripheral Vascular | ||||||||||||
Laparoscopic | ||||||||||||
Musculo-skeletal | ||||||||||||
Superficial | ||||||||||||
Musculo-skeletal Conventional |
N= new indication; P = Previously Cleared by FDA; E = Added under Appendix E (LTF)
Combined Modes: B/M; B/PWD; Additional Comments: BDF/PWD; BDF/MDF; BDF/MDF/PWD;B-TDI; M-TDI; 2D/CWD; BDF/CWD; CHI/2D; FEI/2D; CHI/BDF; FEI/BDF;
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTAINE ON OTHER PAGE Concurrence of CDRH, Office of Deyige Evaluation
(Division Sign-Off) Division of Reproduct and Radiological Devi 510(k) Number
17
Transducer X System PLT-704AT Model 510(k) Number(s)
Mode of Operation | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | B | M | P | |||||||||
W | ||||||||||||
D | C | |||||||||||
W | ||||||||||||
D | Color | |||||||||||
Doppler | Amplitude | |||||||||||
Doppler | Color | |||||||||||
Velocity | ||||||||||||
Imaging | Combined | |||||||||||
(Specify) | Harmonic | |||||||||||
Imaging | 1.5 | |||||||||||
THI | 1.5 | |||||||||||
RSI | TDI-Q | |||||||||||
Ophthalmic | ||||||||||||
Fetal | ||||||||||||
Abdominal | ||||||||||||
Intraoperative (Specify) | ||||||||||||
Intraoperative | ||||||||||||
Neurological | ||||||||||||
Pediatric | ||||||||||||
Small Organ (Specify)*** | E | E | E | E | E | E | E | E | ||||
Neonatal Cephalic | ||||||||||||
Adult Cephalic | ||||||||||||
Cardiac | ||||||||||||
Transesophageal | ||||||||||||
Transrectal | ||||||||||||
Transvaginal | ||||||||||||
Transurethral | ||||||||||||
Intravascular | ||||||||||||
Peripheral Vascular | E | E | E | E | E | E | E | E | ||||
Laparoscopic | ||||||||||||
Musculo-skeletal | ||||||||||||
Superficial | E | E | E | E | E | E | E | E | ||||
Musculo-skeletal | ||||||||||||
Conventional | E | E | E | E | E | E | E | E |
N= new indication; P = Previously Cleared by FDA; E = Added under Appendix E (LTF)
Combined Modes: B/M; B/PWD; Additional Comments: BDF/PWD; BDF/MDF; BDF/MDF/PWD;B-TDI; M-TDI; 2D/CWD; BDF/CWD; CHI/2D; FEI/2D; CHI/BDF; FEI/BDF; FEI/BDF
For example: thyroid, parathyroid, breast, scrotum and penis ***
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON OTHER PAGES IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
David R. Ingram
(Division Sign-Off) Division of Reproductive, Ab and Radiological Device 510(k) Number
18
Transducer X System PLT-1204AT Model 510(k) Number(s)
Mode of Operation | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | B | M | P | |||||||||
W | ||||||||||||
D | C | |||||||||||
W | ||||||||||||
D | Color | |||||||||||
Doppler | Amplitude | |||||||||||
Doppler | Color | |||||||||||
Velocity | ||||||||||||
Imaging | Combined | |||||||||||
(Specify) | Harmonic | |||||||||||
Imaging | 1.5 | |||||||||||
THI | 1.5 | |||||||||||
RSI | TDI-Q | |||||||||||
Ophthalmic | ||||||||||||
Fetal | ||||||||||||
Abdominal | ||||||||||||
Intraoperative (Specify) | ||||||||||||
Intraoperative | ||||||||||||
Neurological | ||||||||||||
Pediatric | ||||||||||||
Small Organ (Specify)*** | E | E | E | E | E | E | E | E | ||||
Neonatal Cephalic | ||||||||||||
Adult Cephalic | ||||||||||||
Cardiac | ||||||||||||
Transesophageal | ||||||||||||
Transrectal | ||||||||||||
Transvaginal | ||||||||||||
Transurethral | ||||||||||||
Intravascular | ||||||||||||
Peripheral Vascular | E | E | E | E | E | E | E | E | ||||
Laparoscopic | ||||||||||||
Musculo-skeletal | ||||||||||||
Superficial | E | E | E | E | E | E | E | E | ||||
Musculo-skeletal | ||||||||||||
Conventional | E | E | E | E | E | E | E | E |
N= new indication; P = Previously Cleared by FDA; E = Added under Appendix E (LTF)
Combined Modes: B/M; B/PWD; Additional Comments: BDF/PWD; BDF/MDF; BDF/MDF/PWD;B-TDI; M-TDI; 2D/CWD; BDF/CWD; CHI/2D; FEI/2D; CHI/BDF; FEI/BDF
For example: thyroid, parathyroid, breast, scrotum and penis ***
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON OTHER PAGES IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
David A. Lipton
(Division Sign-Off Division of Reproductive and Radiological Devi 510(k) Number
19
Transducer _X System _ PVT-375AX Model 510(k) Number(s)
Clinical Application | B | M | P W D | C W D | Color Doppler | Amplitude Doppler | Color Velocity Imaging | Combined (Specify) | Harmonic Imaging | 1.5 THI | 1.5 RSI | TDI-Q |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Ophthalmic | ||||||||||||
Fetal | E | E | E | E | E | E | E | E | ||||
Abdominal | E | E | E | E | E | E | E | E | ||||
Intraoperative (Specify) | ||||||||||||
Intraoperative | ||||||||||||
Neurological | ||||||||||||
Pediatric | E | E | E | E | E | E | E | E | ||||
Small Organ (Specify) | ||||||||||||
Neonatal Cephalic | ||||||||||||
Adult Cephalic | ||||||||||||
Cardiac | ||||||||||||
Transesophageal | ||||||||||||
Transrectal | ||||||||||||
Transvaginal | ||||||||||||
Transurethral | ||||||||||||
Intravascular | ||||||||||||
Peripheral Vascular | ||||||||||||
Laparoscopic | ||||||||||||
Musculo-skeletal | ||||||||||||
Superficial | ||||||||||||
Musculo-skeletal | ||||||||||||
Conventional |
N= new indication; P = Previously Cleared by FDA; E = Added under Appendix E (LTF)
Additional Comments: Combined Modes: B/M; B/PWD; BDF/PWD; BDF/MDF; BDF/MDF/PWD;B-TDI; M-TDI; 2D/CWD; BDF/CWD; CHI/2D; FEI/2D; CHI/BDF; FEI/BDF; FEI/BDF
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON OTHER PAGES IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
Daniel A. Ingram
(Division Sign-O Division of Reproducti and Radiological De 510(k) Numbe
20
Transducer _X System PST-65AT Model 510(k) Number(s)
Mode of Operation | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | B | M | P | |||||||||
W | ||||||||||||
D | C | |||||||||||
W | ||||||||||||
D | Color | |||||||||||
Doppler | Amplitude | |||||||||||
Doppler | Color | |||||||||||
Velocity | ||||||||||||
Imaging | Combined | |||||||||||
(Specify) | Harmonic | |||||||||||
Imaging | 1.5 | |||||||||||
THI | 1.5 | |||||||||||
RSI | TDI-Q | |||||||||||
Ophthalmic | ||||||||||||
Fetal | ||||||||||||
Abdominal | ||||||||||||
Intraoperative (Specify) | ||||||||||||
Intraoperative | ||||||||||||
Neurological | ||||||||||||
Pediatric | E | E | E | E | E | E | E | E | E | |||
Small Organ (Specify) | ||||||||||||
Neonatal Cephalic | E | E | E | E | E | E | E | E | E | |||
Adult Cephalic | ||||||||||||
Cardiac | E | E | E | E | E | E | E | E | E | E | ||
Transesophageal | ||||||||||||
Transrectal | ||||||||||||
Transvaginal | ||||||||||||
Transurethral | ||||||||||||
Intravascular | ||||||||||||
Peripheral Vascular | ||||||||||||
Laparoscopic | ||||||||||||
Musculo-skeletal | ||||||||||||
Superficial | ||||||||||||
Musculo-skeletal | ||||||||||||
Conventional |
N= new indication; P = Previously Cleared by FDA; E = Added under Appendix E (LTF)
Additional Comments: Combined Modes: B/M; B/PWD; BDF/PWD; BDF/MDF; BDF/MDF/PWD;B-TDI; M-TDI; 2D/CWD; BDF/CWD; CHI/2D; FEI/2D; CHI/BDF; FEI/BDF
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON OTHER PAGES IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
David A. Seymore
(Division Sign-O Divis Reproduct and 510(k) Num
21
Transducer_X System -PLT-604AT Model 510(k) Number(s)
Mode of Operation | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | B | M | P | ||||||||||
W | |||||||||||||
D | C | ||||||||||||
W | |||||||||||||
D | Color | ||||||||||||
Doppler | Amplitude | ||||||||||||
Doppler | Color | ||||||||||||
Velocity | |||||||||||||
Imaging | Combined | ||||||||||||
(Specify) | Harmonic | ||||||||||||
Imaging | 1.5 | ||||||||||||
THI | 1.5 | ||||||||||||
RSI | TDI-Q | ||||||||||||
Ophthalmic | |||||||||||||
Fetal | |||||||||||||
Abdominal | |||||||||||||
Intraoperative (Specify) | |||||||||||||
Intraoperative | |||||||||||||
Neurological | |||||||||||||
Pediatric | |||||||||||||
Small Organ (Specify)*** | E | E | E | E | E | E | E | E | |||||
Neonatal Cephalic | |||||||||||||
Adult Cephalic | |||||||||||||
Cardiac | |||||||||||||
Transesophageal | |||||||||||||
Transrectal | |||||||||||||
Transvaginal | |||||||||||||
Transurethral | |||||||||||||
Intravascular | |||||||||||||
Peripheral Vascular | E | E | E | E | E | E | E | E | |||||
Laparoscopic | |||||||||||||
Musculo-skeletal | E | E | E | E | E | E | E | E | |||||
Superficial | |||||||||||||
Musculo-skeletal Conventional | E | E | E | E | E | E | E | E |
N= new indication; P = Previously Cleared by FDA; E = Added under Appendix E (LTF)
Combined Modes: B/M; B/PWD; Additional Comments: BDF/PWD; BDF/MDF; BDF/MDF/PWD;B-TDI; M-TDI; 2D/CWD; BDF/CWD; CHI/2D; FEI/2D; CHI/BDF; FEI/BDF; FEI/BDF
For example: thyroid, parathyroid, breast, scrotum and penis ***
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON OTHER PAGES IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
David h. Segarra
(Division Sign-Off) Division of Reproductive, Ab and Radiological Devices 510(k) Number _
22
Transducer X System Model PST-50AT 510(k) Number(s)
Mode of Operation | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | B | M | P | |||||||||
W | ||||||||||||
D | C | |||||||||||
W | ||||||||||||
D | Color | |||||||||||
Doppler | Amplitude | |||||||||||
Doppler | Color | |||||||||||
Velocity | ||||||||||||
Imaging | Combined | |||||||||||
(Specify) | Harmonic | |||||||||||
Imaging | 1.5 | |||||||||||
THI | 1.5 | |||||||||||
RSI | TDI-Q | |||||||||||
Ophthalmic | ||||||||||||
Fetal | ||||||||||||
Abdominal | ||||||||||||
Intraoperative (Specify) | ||||||||||||
Intraoperative | ||||||||||||
Neurological | ||||||||||||
Pediatric | E | E | E | E | E | E | E | E | E | |||
Small Organ (Specify) | ||||||||||||
Neonatal Cephalic | E | E | E | E | E | E | E | E | E | |||
Adult Cephalic | ||||||||||||
Cardiac | E | E | E | E | E | E | E | E | E | E | N | |
Transesophageal | ||||||||||||
Transrectal | ||||||||||||
Transvaginal | ||||||||||||
Transurethral | ||||||||||||
Intravascular | ||||||||||||
Peripheral Vascular | ||||||||||||
Laparoscopic | ||||||||||||
Musculo-skeletal | ||||||||||||
Superficial | ||||||||||||
Musculo-skeletal | ||||||||||||
Conventional |
N= new indication; P = Previously Cleared by FDA; E = Added under Appendix E (LTF)
Combined Modes: B/M; B/PWD; Additional Comments: BDF/PWD; BDF/MDF; BDF/MDF/PWD;B-TDI; M-TDI; 2D/CWD; BDF/CWD; CHI/2D; FEI/2D; CHI/BDF; FEI/BDF
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON OTHER PAGES IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
David A. Bergman
(Division Sign-Off) Division of Reproductive, Abdon and Radiological Devices 510(k) Number
23
System Transducer X PLT-308P Model 510(k) Number(s)
Mode of Operation | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical Application | B | M | P W D | C W D | Color | |||||||
Doppler | Amplitude | |||||||||||
Doppler | Color | |||||||||||
Velocity | ||||||||||||
Imaging | Combined | |||||||||||
(Specify) | Harmonic | |||||||||||
Imaging | 1.5 | |||||||||||
THI | 1.5 | |||||||||||
RSI | TDI-Q | |||||||||||
Ophthalmic | ||||||||||||
Fetal | ||||||||||||
Abdominal | E | E | E | E | E | E | E | E | E | |||
Intraoperative (Specify) | E | E | E | E | E | E | E | E | E | |||
Intraoperative | ||||||||||||
Neurological | ||||||||||||
Pediatric | E | E | E | E | E | E | E | E | E | |||
Small Organ (Specify) | ||||||||||||
Neonatal Cephalic | ||||||||||||
Adult Cephalic | ||||||||||||
Cardiac | ||||||||||||
Transesophageal | ||||||||||||
Transrectal | ||||||||||||
Transvaginal | ||||||||||||
Transurethral | ||||||||||||
Intravascular | ||||||||||||
Peripheral Vascular | ||||||||||||
Laparoscopic | ||||||||||||
Musculo-skeletal | ||||||||||||
Superficial | ||||||||||||
Musculo-skeletal | ||||||||||||
Conventional |
N= new indication; P = Previously Cleared by FDA; E = Added under Appendix E (LTF)
Combined Modes: B/M; B/PWD; Additional Comments: BDF/PWD; BDF/MDF; BDF/MDF/PWD;B-TDI; M-TDI; 2D/CWD; BDF/CWD; CHI/2D; FEI/2D; CHI/BDF; FEI/BDF; FEI/BDF
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON OTHER PAGES IF NEEDED! Concurrence of CDRH, Office of Device Evaluation (ODE)
Daniel A. Segner
(Division Sign-Off) Division of Reproductive, Abdomin and Radiological Devices 510(k) Number